Postdoctoral Researchers

Inma Conejos Sanchez

Position: Postdoctoral Researcher
Telephone: 
Email: inma.conejos.sanchez@gmail.com

Inma obtained her degree in chemistry at the University of Valencia (Spain) in July 2007, after her Erasmus year in the Institute of Nuclear Chemistry at the University Johnannes Gutenberg in Mainz (Germany). She then joined the Polymer Therapeutics lab to undertake a project entitled “Polymer-drug conjugates for the treatment of neurodegenerative disorders”. During this period, she was involved in the development and validation of new versatile and controlled polyglutamates-based carriers, studies into strategies to overcome biological barriers such as the blood-brain barrier by means of active targeting with these polymeric platforms, and also the design, synthesis, and validation of novel polymer conjugates for the treatment of the treatment of rare neurological diseases. The latest project involved a short stay in the Dr. Saraiva’s group in Porto (Portugal). After obtaining her cum laude PhD, she joined the Biomaterials Group of Dr. Iraida Loinaz in IK4-CIDETEC (San Sebastián, Spain), a re-known scientific technology center in the field of nanomedicine and drug delivery, where she participated in the European project SaveMe, based on the construction of a modular active nano-platform for diagnoses and cancer treatment. Her work dealt with the development of single chain nanoparticles synthesis and characterization, the improvement of their targeting/labeling methodologies and the escalation procedures. In March 2014, she moved to the group of Prof. María José Alonso, a widely known scientist for her contributions to vaccine/drug delivery nanocarriers, pioneering this area in Spain. Her research in the European project Trans-Int pursued the design and development of nanoformulations for peptide oral delivery. In July 2015, she was awarded with a postdoctoral grant between her PhD lab and the Department of Clinical Neuroscience in the University of Cambridge (United Kingdom). Her project is focused in the design, develop and biologically evaluation of novel non-viral gene delivery vectors for treatment of progressive forms of multiple sclerosis using siRNA as the bioactive molecule.

Zoraida Andreu Martinez

Position: Post-Doctoral Researcher
Telephone: +34 963289680 (Ext 2314)
Email: zandreu@cipf.es

Dr. Zoraida Andreu, trained as predoctoral fellow in the laboratory of Dra. Helena Mira Aparicio with a focus on neurogenesis in the hippocampus and the regulation of neural stem cells. She worked extensively on morphogenetic bone protein (BMP) signalling and cell cycle inhibitors (CKIs) in collaboration with the goup of Dra. Isabel Fariñas. In 2011, Zoraida joined the lab of Dr. Fernando Vidal Vanaclocha´s at the CEU San Pablo University as a junior researcher to study the role of astroglia and the microenviroment in brain metastasis. During this period, Zoraida was also involved in a project on epilepsy in collaboration with Dr, Jesus Pastor Gómez at the Hospital La Princesa. In 2014, Zoraida joined the Research Unit at the Santa Cristina University Hospital within the Institute of Health Research Princesa (IIS-IP) with  a Juan de la Cierva contract. She worked as a postdoctoral researcher studying "Microdomains of membrane in immunity". There, she completed a series of studies aimed at the use of exosomes as non-invasive biomarkers of disease, in collaboration with clinical groups of the IIS-IP. These studies are part of an intramural project of excellence, focused on the search for biomarkers of prognosis of response to biological drugs in autoimmune diseases. This included studies in bladder cancer, addressed in collaboration with the Urology Service led by Dr Olivier. Zoraida also carried out basic studies aimed at elucidating the role of tetraspanins in the biogenesis of exosomes and the potential anti-metastatic therapeutic use of cytopermeable peptides directed against said molecules. These studies have been carried out in collaboration with the group of Dr Hector Peinado in the CNIO. In 2017 she joined the Polymer Therapeutics lab to develop the study of exosomes as therapeutic targets in breast cancer treatment.

Katia Maso

Position: Post-Doctoral Researcher
Telephone: +34 963289680 (Ext 2314)
Email: kmaso@cipf.es

Dr Katia Maso obtained her Master’s degree in Pharmaceutical Chemistry and Technology at the University of Padova (Italy) in 2013. After that, she was awarded with a postgraduate scholarship and joined the Drug Delivery lab of Prof Gianfranco Pasut to conduct studies on protein PEGylation. In November 2014, she enrolled as a PhD student in the Graduate Course in Molecular Sciences at the University of Padova. She worked under Prof Pasut’s supervision on her dissertation project, which was centred on the development of new drug delivery systems formed by a drug-bearing moiety that non-covalently binds the Fc region of a targeting antibody. She also took part in other projects, including the synthesis and characterization of protein conjugates to anionic PEG copolymers and the use of new type of linkers for antibody-drug conjugates. During her PhD program, Katia spent seven months in the lab of Prof Silvia Muro at the University of Maryland (College Park, MD, USA), where she evaluated the binding and the internalization of a protein-antibody system targeted to ICAM-1 receptor in a cellular model. In particular, she used human umbilical endothelial cells that, in pathological conditions, over-express the ICAM-1 receptor. In January 2018, she moved to the group of Dr Maria Jesus Vicent at the Polymer Therapeutic Lab (Centro de Investigación Principe Felipe, Valencia, Spain) for a post-doctoral fellowship focused on the design of new antibody-drug conjugates for prostate cancer and of new targeted polymer therapeutics for breast cancer.

Alessio Malfanti

Position: Post-Doctoral Researcher
Telephone: +34 963289680 (Ext 2314)
Email: amalfanti@cipf.es

Alessio Malfanti obtained his master degree “cum laude” in Pharmaceutical Chemistry and Technology (Chimica e tecnologia farmaceutiche) in 2013 at The Università degli Studi di Torino (Italy). His master thesis was supervised by Prof. Silvia Arpicco and was focused on the synthesis and delivery of gemcitabine prodrugs using mesoporous silica nanoparticles. During his Masters, he spent 6 months in Saint-Antoine Hospital in Paris by the Erasmus program. In April 2014, he moved to the Drug Delivery Unit at the Department of Pharmaceutical and Pharmacological Sciences in Padova under the supervision of Prof. Paolo Caliceti. During his Ph.D., Alessio was involved in the development of poly-cationic polymeric nanoplatforms with unconventional structures for delivery of oligonucleotides. In particular, his work was focused on the synthesis of a polymer library using Atom Transfer Radical Polymerization (ATRP). During his Ph.D., Alessio had the chance to work for several months in Prof. Ronit Satchi-Fainaro’s Lab at Tel Aviv University in Israel where he performed the in vitro and in vivo studies of the new nanocarriers for siRNA delivery. Furthermore, working in the Drug Delivery Unit at University of Padova he had the opportunity to study new strategies for the delivery of therapeutic proteins with structural fragility using self-assembling nanocarriers. In his last period in the Drug Delivery Unit, he was supervised by Prof. Stefano Salmaso and his main work was focused on the delivery of poorly soluble small drug with strong activity against Hedgehog-dependent brain tumors to increase biopharmaceutical properties. This project was in collaboration with the University “La Sapienza” of Rome (Italy). In January 2018, he joined the Polymer Therapeutics lab (Valencia, Spain) and his work will be focused on the ERC grants MyNano and IMMUNOCURE.